MATERIALIZE BIO, INC.

Medtech · Private

Bioengineered ear tubes made from natural materials with on-demand removal capability

Grants
$1.5M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Bioengineered Next-Generation Tympanostomy Tubes to Improve Patient Outcomes$274,999
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Bioengineered Next-Generation Tympanostomy Tubes to Improve Patient Outcomes$1,250,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1223EFEMORAL MEDICAL, INC.—$4.7M
1224Happy Fireflies Ltd Liability Co—$2.0M
1225VINE MEDICAL, INC.—$50K
1226MATERIALIZE BIO, INC.——
1227Parallel Fluidics, Inc.—$5.2M
1228CathAid Inc—$1.2M
1229EPIC Imaging, P.C.—$222K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.